Literature DB >> 12763664

A functionalized cobalt(III) mixed-polypyridyl complex as a newly designed DNA molecular light switch.

Qian-Ling Zhang1, Jian-Hong Liu, Xiang-Zhong Ren, Hong Xu, Yi Huang, Jian-Zhong Liu, Liang-Nian Ji.   

Abstract

The ligand ODHIP (3,4-dihydroxyl-imidazo[4,5-f][1,10]phenanthroline) and its cobalt(III) complex [Co(bpy)(2)(ODHIP)](3+) were synthesized and characterized. Binding of this complex with calf thymus DNA has been investigated by spectroscopic methods and viscosity. The experimental results indicated that the complex bound to DNA by intercalation. In Tris buffer, the complex could emit relatively weak luminescence. After binding to DNA, the notable enhancement was observed. However, when the Cu(2+) was further added, the luminescence decreased gradually and disappeared after the equimolar concentrations of Cu(2+) was added, which exhibited the "off-on-off" properties of molecular light switch.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12763664     DOI: 10.1016/s0162-0134(03)00122-3

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  3 in total

1.  Synthesis, micellization behaviour, DNA/RNA binding and biological studies of a surfactant cobalt(III) complex with dipyrido[3,2-a:2',4'-c](6,7,8,9-tetrahydro)phenazine.

Authors:  Karuppiah Nagaraj; Krishnan Senthil Murugan; Pilavadi Thangamuniyandi; Subramanian Sakthinathan
Journal:  J Fluoresc       Date:  2014-09-27       Impact factor: 2.217

2.  Photoluminescent DNA binding and cytotoxic activity of a platinum(II) complex bearing a tetradentate β-diketiminate ligand.

Authors:  Jennifer M Hope; Justin J Wilson; Stephen J Lippard
Journal:  Dalton Trans       Date:  2012-11-12       Impact factor: 4.390

3.  Transition metal complexes of quinolino[3,2-b]benzodiazepine and quinolino[3,2-b]benzoxazepine: synthesis, characterization, and antimicrobial studies.

Authors:  B Basavaraju; Halehatty S Bhojya Naik; Mustur C Prabhakara
Journal:  Bioinorg Chem Appl       Date:  2007       Impact factor: 7.778

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.